Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Moderna
February 28, 2022 06:02 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...